AstraZeneca, Shire dive as U.S. tax move punctures deal hopes
September 23, 2014 at 07:54 AM EDT
A day after Treasury took steps to curb inversion deals allowing companies to escape high U.S. taxes, shares of drugmakers AstraZeneca, Shire fell sharply.
